Alverno Laboratories Selects Ibex’s AI Solution for Cancer Diagnostics

Alverno Laboratories, a provider of high-quality diagnostic testing services and one of the largest integrated laboratory networks in the United States, and Ibex Medical Analytics, the market leader in artificial intelligence (AI)-powered cancer diagnostics, today announced a deal to deploy Ibex’s AI-powered Galen platform, helping pathologists provide accurate diagnosis and improved care for cancer patients.

Pathologists play a crucial role in the detection and diagnosis of disease, with their assessments vital in reaching correct treatment decisions by oncologists. However, a rise in cancer prevalence and advances in personalized medicine have resulted in growing diagnostic complexity that significantly increases pathologists’ workloads. In recent years, as pathology labs transition towards digital solutions, laboratories can implement AI enhanced workflows to improve the quality and efficiency of cancer diagnosis, resulting in better patient care.